US Patent Issued to Biogen MA on Sept. 30 for "Neurofilament protein for guiding therapeutic intervention in amyotrophic lateral sclerosis" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,429,487, issued on Sept. 30, was assigned to Biogen MA Inc. (Cambridge, Mass.).

"Neurofilament protein for guiding therapeutic intervention in amyotrophic lateral sclerosis" was invented by Toby Arlo Ferguson (Concord, Mass.), Danielle LeeZetta Graham (Concord, Mass.), Steve Sang-Woo Han (Needham, Mass.), Alexander Reid Vincent McCampbell (Andover, Mass.) and Giulio Srubek-Tomassy (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the invention provides a method for alleviating a symptom in a patient with amyotrophic lateral sclerosis, comprising administering an efficacious therapeutic that is efficacious to the patient, t...